Isolation and ex vivo expansion of human umbilical cord blood-derived CD34⁺ stem cells and their cotransplantation with or without mesenchymal stem cells

References

• Barker JN, Krepski TP, Defor TE, Davies SM, Wagner JE, Weisdorf DJ. Searching for unrelated donor Hematopoietic stem cells: avability and speed of umbilical cord blood versus bone marrow. Biol Blood Marrow Transplant 2002; 8: 257–260.
   PubMed Web of Science ®Google Scholar
• Rocha V, Cornish J, Sievers EL, et al. Comparison of outcomes ofunrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood 2001; 97(10): 2962–2971.
   PubMed Web of Science ®Google Scholar
• Barker JN, Wagner JE. Umbilical cord blood transplantation: current practice and future innovations. Hematology 2003; 48: 35–43.
   Web of Science ®Google Scholar
• Mayani H, Lansdorp PM. Biology of human umbilical cord blood-derived hematopoietic stem/progenitor cells. Stem Cells 1998; 16: 153–165.
   PubMed Web of Science ®Google Scholar
• Wynter EA, Emmerson AJB, Testa NG. Properties of peripheralblood and cord blood stem cells. Baillieres Clin Haematol 1999; 1/2: 1–17.
   Web of Science ®Google Scholar
• Leung W, Ramirez M, Novelli EM, et al. In vivo engraftment potential of clinical hematopoietic grafts. J Invest Med 1998; 46(6): 303–311.
   PubMed Web of Science ®Google Scholar
• Lewis I, Verfaillie CM. Multi-lineage expansion potential of primitive hematopoietic progenitors. Superiority of umbilical cord blood compared to mobilized peripheral blood. Exp Hematol 2000; 28(9): 1087–1095.
   PubMed Web of Science ®Google Scholar
• Gluckman E, Broxmeyer HA, Auerbach AD, et al. Hematopoieticreconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med 1989; 321: 1174–1178.
   PubMed Web of Science ®Google Scholar
• Issaragrisil S, Visuthisakchai S, Tangnaitrisorana Y, et al. Collection of cord blood stem cells for transplantation in thalassemic patients. Stem Cells 1995; 13\(Suppl 3): 71–75.
   PubMed Web of Science ®Google Scholar
• Rocha V, Wagner JE, Sobocinski KA, et al. Graft-versus-host disease in children who have received a cord blood or bone marrow transplant from an HLA-identical sibling. N Engl J Med 2000; 342(25): 1846–1854.
   PubMed Web of Science ®Google Scholar
• Gluckman E, Rocha V, Boyer-Chammard A, et al Eurocord Transplant Group and the European Blood and Marrow Transplantation Group Outcome of cord-blood transplantation from related and unrelated donors. N Engl J Med 1997; 337(6): 373–381.
   PubMed Web of Science ®Google Scholar
• Gluckman E, Rocha V, Chevret S. Results of unrelated umbilical cord blood hematopoietic stem cell transplantation. Rev Clin Exp Hematol 2002; 5(2): 87–99.
   Google Scholar
• Wagner JE, Barker JN, DeFor TE, et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 2002; 100(5): 1611–1618.
   PubMed Web of Science ®Google Scholar
• Laughlin MJ, Barker J, Bambach B, et al. Hematopoietic engraftment and survival in adult recipients of umbilicalcord blood from unrelated donors. N Engl J Med 2001; 344(24): 1815–1822.
   PubMed Web of Science ®Google Scholar
• Sanz GF, Saavedra S, Planelles D, et al. Standardized, unrelated donor cord blood transplantation in adults with hematologic malignancies. Blood 2001; 15(98): 2332–2338.
   Web of Science ®Google Scholar
• Peled P, Iudin D, Gluckman E, Adi S, Hasson N, Treves A. Copper chelators enable long term CFU and CD34+ cells expansion in cultures initiated with the entire mono nuclear cell (MNC) fraction. Blood 2002; 100(11): abstract no. 4076.
   Web of Science ®Google Scholar
• Jaroscak J, Martin P, Waters-Pick B, et al. A phase I trial of augmentation of unrelated umbilical cord blood transplantation with ex-vivo expanded cells. Blood 1998; 92: 646–649.
   Web of Science ®Google Scholar
• Kirsten B, Joaquim MS, Esmail D, et al. A human stromal-based serum-free culture system supports the ex vivo expansion/main-tenance of bone marrow and cord blood hematopoietic stem/ progenitor cells. Exp Hematol 2005; 33: 825–835.
   Web of Science ®Google Scholar
• Lazzari L, Lucchi S, Rebulla P, et al. Long-term expansion and maintenance of cord blood haematopoietic stem cells using thrombopoietin, F1t3-ligand, interleukin(IL-6) and IL-11 in a serum-free and stroma-free culture system. Br J Hematol 2001; 112: 397–404.
   PubMed Web of Science ®Google Scholar
• Bruno S, Gammaitoni L, Gunetti M, et al. Different growth factor requirements for the ex vivo amplification of transplantable human cord blood cells in a NOD/SCID mouse model. J Biol Regul Homeost Agents 2001; 15: 38–48.
   PubMed Web of Science ®Google Scholar
• Piacibello W, Sanavio F, Garetto L, et al. Extensive amplification and self-renewal of human primitive hematopoietic stem cells from cord blood. Blood 1997; 89: 2644–2653.
   PubMed Web of Science ®Google Scholar
• De Felice L, Di Pucchio T, Mascolo MG, et al. F1t3L induces the ex vivo amplification of umbilical cord blood committed progeni-tors and early stem cells in short-term cultures. Br J Haematol 1999; 106: 133–141.
   PubMed Web of Science ®Google Scholar
• Kawada H, Ando K, Tsuji T, et al. Rapid ex vivo expansion of human umbilical cord hematopoietic progenitors using a novel culture system. Exp Hematol 1999; 27: 904–915.
   PubMed Web of Science ®Google Scholar
• McNiece IK, Almeida-Porada G, Shpall EJ, Zanjani E. Ex vivo expanded cord blood cells provide rapid engraftment in fetal sheep but lack long-term engrafting potential. Exp Hematol 2002; 30: 612–616.
   PubMed Web of Science ®Google Scholar
• Angelopoulou M, Novelli E, Grove JE, Rinder HM. Cotransplantation of human mesenchymal stem cells enhances human myelopoieisis and megakaryocytopoeisis in NOD/SCID mice. Exp Hematol 2003; 31: 413–420.
   PubMed Web of Science ®Google Scholar
• Alma J, Alwine B, Frans H, Willy A, Willem E. Enhanced engraftment of umbilical cord blood-derived stem cells in NOD/ SCID mice by cotransplantation of a second unrelated cord blood unit. Exp Hematol 2005; 33: 1249–1256.
   PubMed Web of Science ®Google Scholar
• Han JY, Goh RH, Seo SY, et al. Cotransplantation of cord bloodhematopoietic stem cells and culture-expanded and GM-CSF-/ SCF-transfected mesenchymal stem cells in SCID mice. J Korean Med Sci 2007; 22: 242–247.
   PubMed Web of Science ®Google Scholar
• Kassem M. Mesenchymal stem cells: biological characteristics and potential clinical applications. Cloning Stem Cells 2004; 6: 369–374.
   PubMedGoogle Scholar
• Le Blanc K, Pittenger MF. Mesenchymal stem cells: progress toward promise. Cytotherapy 2005; 7: 36–45.
   PubMed Web of Science ®Google Scholar
• Kan I, Melamed E, Offen D. Integral therapeutic potential of bonemarrow mesenchymal stem cells. Curr Drug Targets 2005; 6: 31–41.
   PubMed Web of Science ®Google Scholar
• Jiang Y, Jahagirdar BN, Reinhardt RL, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002; 418: 41–49.
   PubMed Web of Science ®Google Scholar
• Jones EA, Kinsey SE, English A, et al. Isolation and characteriza-tion of bone marrow multipotential mesenchymal progenitor cells. Arthritis Rheum 2002; 46: 3349–3360.
   PubMed Web of Science ®Google Scholar
• Stelzer GT, Shults KE, Loken MR. CD45 gating for routine flow cytometric analysis of human bone marrow specimens. Ann NY Acad Sci 1993; 677: 265–280.
   PubMed Web of Science ®Google Scholar
• Digirolamo CM, Stokes D, Colter D, et al. Propagation and senescence of human marrow stromal cells in culture: a simple colony-forming assay identifies samples with the greatest potential to propagate and differentiate. Br J Haematol 1999; 107: 275–281.
   PubMed Web of Science ®Google Scholar
• Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143–147.
   PubMed Web of Science ®Google Scholar
• Perez LE, Rinder HM, Wang C, Tracey JB, Maun N. Xenotransplantation of immunodeficient mice with mobilized human blood CD34_ cells provides an in vivo model for human megakaryocytopoiesis and platelet production. Blood 2001; 97: 1635–1643.
   PubMed Web of Science ®Google Scholar
• Devine SM, Cobbs C, Jennings M, Bartholomew A, Hoffman R. Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates. Blood 2003; 101(8): 2999–3001.
   PubMed Web of Science ®Google Scholar
• Noort WA, Kruisselbrink AB, in't Anker PS, et al. Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34 ± cells in NOD/SCID mice. Exp Hematol 2002; 30: 870–878.
   PubMed Web of Science ®Google Scholar
• Kim DH, Yoo KH, Yim YS, et al. Cotransplanted bone marrow derived mesenchymal stem cells (MSC) enhanced engraft-ment of hematopoietic stem cells in a MSC-dose dependent manner in NOD/SCID mice. J Korean Med Sci 2006; 21: 1000–1004.
   PubMed Web of Science ®Google Scholar
• Cheng L, Qasba P, Vanguri P, Thiede MA. Human mesenchymal stem cells support megakaryocyte and pro-platelet formation from CD34-hematopoietic progenitor cells. J Cell Physiol 2000; 184: 58–69.
   PubMed Web of Science ®Google Scholar
• Koc ON, Gerson SL, Cooper BW, et al. Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol 2000; 18: 307–316.
   PubMed Web of Science ®Google Scholar
• Fibbe WE, Noort WA, Schipper F, Willemze R. Ex vivo expansion and engraftment potential of cord blood-derived CD34- cells in NOD/SCID mice. Ann NY Acad Sci 2001; 938: 9–17.
   PubMed Web of Science ®Google Scholar
• Nilsson SK, Johnston HM, Coverdale JA. Spatial localization of transplanted hemopoietic stem cells: inferences for the localization of stem cell niches. Blood 2001; 97: 2293–2296.
   PubMed Web of Science ®Google Scholar
• Cheng L, Qasba P, Vanguri P, Thiede MA. Human mesenchymal stem cells support megakaryocyte and pro-platelet formation from CD34 ± hematopoietic progenitor cells. J Cell Physiol 2000; 184: 58–69.
   PubMed Web of Science ®Google Scholar
• Bittencourt MC, Perruche S, Contassot E, et al. Intravenous injection of apoptotic leukocytes enhances bone marrow engraft-ment across major histocompatibility barriers. Blood 2001; 98: 224–230.
   PubMed Web of Science ®Google Scholar
• Majumdar MK, Thiede MA, Mosca JD, Moorman M, Gerson SL. Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells. J Cell Physiol 1998; 176: 57–66.
   PubMed Web of Science ®Google Scholar
• Haynesworth SE, Baber MA, Caplan Al. Cell surface antigens on human marrow-derived mesenchymal cells are detected by mono-clonal antibodies. Bone 1992; 13: 69–80.
   PubMed Web of Science ®Google Scholar
• Mbalaviele G, Jaiswal N, Meng A, Cheng L, Van Den Bos C, Thiede M. Human mesenchymal stem cells promote human osteoclast differentiation from CD34_ bone marrow hematopoietic progenitors. Endocrinology 1999; 140: 3736–3743.
   PubMed Web of Science ®Google Scholar